Recurrent miscarriage: could this devastating condition have a simple cure?
Recurrent miscarriages are often caused by endometriosis, a condition that affects one in ten women...
Read More...
Focus:
-
![Astellas Pharma to acquire Audentes Therapeutics for $3bn]()
Astellas Pharma to acquire Audentes Therapeutics for $3bn
Astellas Pharma has signed an agreement to acquire genetic drugs developer Audentes Therapeutics for a...
Read More...
-
![Baker Bros Kodiak invest eye disease]()
Baker Bros invests $225m for stake in Kodiak’s eye disease drug
Eye disease-focused Kodiak Sciences has entered into a funding agreement with Baker Bros Advisors, in...
Read More...
-
![manipulated data Novartis]()
The problem of manipulated data
In August, the FDA accused Novartis of submitting a drug application with manipulated data and...
Read More...
-
![China cut drug prices]()
Big pharma agrees to drastically cut prices of blockbuster drugs in China
The Chinese National Healthcare Security Administration (NHSA) has announced it has agreed an average 61%...
Read More...
-
![ADCs targeted cancer treatment]()
A safer ride: the latest innovation in targeted cancer treatment
One downside of the antibody-drug conjugates used in oncology today is that the drug-carrying antibodies...
Read More...
-
![NICE Pfizer Ibrance CDF]()
NICE recommends Pfizer’s Ibrance for NHS use through the CDF
Pfizer has announced the UK’s pricing regulator the National Institute of Health and Social Care...
Read More...
-
![repatriating drug production]()
Debate: should countries bring critical drug production home?
Regulatory breaches at drug manufacturing sites in India and China have fuelled concerns over the...
Read More...
-
![pancreatic cancer awareness immunotherapy]()
Making immunotherapy effective in pancreatic cancer
Immunotherapies have transformed treatment of cancers over the past few decades, but one cancer type...
Read More...
-
![Ardelyx Kyowa Kirin partnership]()
Ardelyx and Kyowa Kirin expand drug development partnership
Kyowa Kirin has announced an expansion of its collaboration with specialised biotech Ardelyx regarding the...
Read More...
